Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

NCT01915407 is registered in ClinicalTrials.gov with Aggredyne, Inc. as lead sponsor.

NCT NCT01915407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01915407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction
Lead sponsor
Aggredyne, Inc.
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
July 31, 2013
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

platelet dysfunction due to aspirin ingestion